Adil S. A. Al Hinai

Molecular characterization of mutant <i>TP53</i> acute myeloid leukemia and high-risk myelodysplastic syndrome

Tim Grob, Adil S. A. Al Hinai, Mathijs A. Sanders et al. · Blood · 2022 · 290 citations · Full text

Medicine, Hematology, Molecular Genetics +17

MBD4 guards against methylation damage and germ line deficiency predisposes to clonal hematopoiesis and early-onset AML

Mathijs A. Sanders, Edward Chew, Christoffer Flensburg et al. · Blood · 2018 · 115 citations · Full text

Life Sciences, Genetics, Hematology +17

Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations

Jonas S. Jutzi, Titiksha Basu, Maximilian Pellmann et al. · Blood · 2019 · 38 citations · Full text

Medicine, Molecular Genetics, Oncology +12

Microarray Gene Expression Analysis to Evaluate Cell Type Specific Expression of Targets Relevant for Immunotherapy of Hematological Malignancies

Margot J. Pont, M. Willy Honders, Anita N. Kremer et al. · PLoS ONE · 2016 · 20 citations · Full text

Life Sciences, Immunology, Oncology +15

PPM1D mutations appear in complete remission after exposure to chemotherapy without predicting emerging AML relapse

Adil S. A. Al Hinai, Tim Grob, Melissa Rijken et al. · Leukemia · 2021 · 10 citations

Medicine, Genetics, Molecular Genetics +15